DFFN
$0.70
Diffusion Pharmaceuticals
($.03)
(3.65%)
DFFN
Earnings Whisper ®
N/A
4th Quarter December 2020
Consensus:  ($0.05)
Revenue:  $0.00 Mil
Thursday
Feb 11
4:00 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when DFFN reports earnings?
Beat
Meet
Miss

Where is DFFN's stock price going from here?
Up
Flat
Down
Stock chart of DFFN
Analysts
Summary of analysts' recommendations for DFFN
Score
Grade
Pivots
Resistance
$0.79
$0.76
$0.74

$0.71

Support
$0.69
$0.66
$0.65
Tweet
Growth
Description
Diffusion Pharmaceuticals Inc. is a biotechnology company. Its product pipeline includes Trans Sodium Crocetinate, Glioblastoma Program, Pancreatic Cancer Program and Brain Metastases Program. The Company is focused on cancer treatments, such as radiation therapy and chemotherapy in treatment-resistant solid tumors. Diffusion Pharmaceuticals Inc., formerly known as RestorGenex Corporation, is based in Charlottesville, United States.